Skip to content

Medivelt

Active
Private limited companyfounded 20233 yrs activeDorpsplein 9, 3020 Herent, BelgiumKBO/BCE: BE 1000.393.266
Summary

Medivelt has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€1,665) and a net result of €3,158. Its solvency ranks better than 5% of 19338 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Activity
General medical practice
NACE 86210
1 site
Size
€11,501total assets 2025
Staff
2 FTE
Equity
-€1,665
Profit
€3,158
Turnover not published (abridged schema)
Financial health
55 Fair Checked score 2025
Bankruptcy chance 12 m
0.1%
Structure
Largest shareholder
Dr. Elke Polspoel huisartsgeneeskunde · 33.33%
Board
1 member
Accounts filed 9 d late1 of 4 deeds read
Why 55Capped at 59: negative equity- Negative equity -€1,665+ Sector Human health activities (NACE 86)+ Size: total assets €11,501+ Figures for FY 2025 (filed 09-08-2026)Show the evidence

Checked score

Score 2025
55 / 100
Fair
Probability in this band: 1.5% to 4.2%
Better than 45% of its sector peers (NACE 86, micro)
Performance against the sector, not lower risk
Negative equity caps the score at 59. Every signal that weighs is under Signals.
Financial strength · tick = 2024
Average
Solvency 11+11
equity -14.5% of total assets
Liquidity 44+38
short-term debt 90.2% · cash 35.1%
Profitability 100+100
return on assets 27.5%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (23,682 companies)
Last 24 months 11-2024: 0.3% 12-2024: 0.3%▲ +2.3% vs 11-2024 01-2025: 0.3%▲ +0.9% vs 12-2024 02-2025: 0.3%● 0.0% vs 01-2025 03-2025: 0.4%▲ +9.4% vs 02-2025 04-2025: 0.4%● 0.0% vs 03-2025 05-2025: 0.4%▲ +8.3% vs 04-2025 06-2025: 0.4%▲ +6.3% vs 05-2025 07-2025: 0.2%▼ -40.7% vs 06-2025 08-2025: 0.2%● 0.0% vs 07-2025 09-2025: 0.2%▲ +2.5% vs 08-2025 10-2025: 0.3%▲ +9.8% vs 09-2025 11-2025: 0.3%● 0.0% vs 10-2025 12-2025: 0.3%● 0.0% vs 11-2025 01-2026: 0.3%▲ +2.2% vs 12-2025 02-2026: 0.3%● 0.0% vs 01-2026 03-2026: 0.3%▲ +21.8% vs 02-2026 04-2026: 0.3%● 0.0% vs 03-2026 05-2026: 0.3%● 0.0% vs 04-2026 06-2026: 0.3%▲ +1.5% vs 05-2026 07-2026: 0.4%▲ +13.8% vs 06-2026 08-2026: 0.6%▲ +57.1% vs 07-2026highest value 09-2026: 0.1%▼ -88.3% vs 08-2026lowest value 10-2026: 0.1%● 0.0% vs 09-2026lowest value
  • Sector Human health activities (NACE 86) lowers the probability
  • Negative equity -€1,665 raises the probability
  • Size: total assets €11,501 lowers the probability for this profile
  • Figures for FY 2025 (filed 09-08-2026) lowers the probability
No credit on open account
Liquidity tight (current ratio 1.11 against 0.86 in 2024; short-term debt: 90.2% and cash: 35.1% of total assets), and equity is negative.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 86, micro). Better than this share of them on solvency 2%, liquidity 12%, profitability 80%, growth against the median 84%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 03-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Sector Human health activities (NACE 86)
In the bankruptcy model this factor lowers the probability.
KBO
raises risk · Negative equity -€1,665
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
lowers risk · Size: total assets €11,501
In the bankruptcy model this factor lowers the probability for this profile.
NBB · annual accounts
lowers risk · Figures for FY 2025 (filed 09-08-2026)
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 19338 sector peers (2025).
NBB · sector comparison
Position among 19338 sector peers
Solvency
better than 5%
← weakest strongest →
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-08-2026, 9 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 2 filings
Deviation from the deadline
2025
9 d late
2024
43 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 17 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
03-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Appointment: Dr. Laura Luykx (director)Permanent representative: Laura Luykx
  2. Annual accounts filedfiscal year 2025 · micro…
  3. Back to profitnet €3,158

Key points

  • Risk: Negative equityfiscal year 2025: debts exceed assets -€1,665 View
  • Caution: Among the weakest 5% on solvencysector median 63.5% · 19,338 companies -14.5% View
  • New directorlatest change 01-09-2026 · 1 in office 1 joined View

By topic

Financials

Fiscal year
2025
Total assets
€11,501
Profit
€3,158
Solvency
-14.5%
Total assets▲ 88.3%
Net result
20242025
Go to Financials

Board & ownership

Board
1 member
Largest shareholder
Dr. Elke Polspoel huisartsgeneeskunde · 33.33%
Go to Board & ownership

Timeline

Events
4
Since
2025
Next accounts
by 31-07-2027
  1. 23-09-2026Appointment: Dr. Laura Luykx (director)
  2. 09-08-2026Annual accounts filed
  3. 31-12-2025Back to profit
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
General medical practiceNACE 86210
Founded
27-09-2023
Year ends
31-12
Peppol
Not found in the Peppol directory
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.